A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Gunduz, Ozge, Modi, Zateen, Modi, Deepak
Materialtyp: Online
Språk:engelska
Publicerad: International Association for Dental Research (Nigeria Division) 2019
Länkar:https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk

Liknande verk